U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07307456) titled 'Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration' on Dec. 14.
Brief Summary: This is a single-center, prospective, open-label, non-randomized clinical study initiated and conducted by the Department of Urology, Shanghai Changhai Hospital. The Principal Investigators are Professor Zhang Zhensheng and Professor Chen Guanghua. The projected study period is from December 2025 to December 2028. This study aims to evaluate the efficacy and safety of toripalimab (a PD-1 inhibitor) combined with Bacillus Calmette-Guerin (BCG) intravesical instillation as adjuvant therapy following transu...